ScarX is developing the world's first prescription drug to reduce skin scarring; targeting a market size of over US$10 billion worldwide.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free